NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Oct 28, 2026 10-Q
8-K Oct 28, 2026 8-K
4 Oct 5, 2026 FORM 4
8-K Oct 5, 2026 8-K
4 Sep 3, 2026 FORM 4
4 Aug 25, 2026 FORM 4
S-8 Aug 25, 2026 S-8
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 11, 2026 8-K
4 Aug 6, 2026 FORM 4
144 Aug 4, 2026
144 Jul 30, 2026
SCHEDULE 13G/A Jul 30, 2026
SCHEDULE 13G Jul 30, 2026
10-Q Jul 28, 2026 10-Q
8-K Jul 28, 2026 8-K
8-K/A Jul 22, 2026 8-K/A
8-K Jul 20, 2026 8-K
4 Jun 25, 2026 FORM 4
3 Jun 25, 2026 FORM 3
8-K Jun 25, 2026 8-K
8-K Jun 22, 2026 8-K
4 Jun 17, 2026 FORM 4
8-K Jun 17, 2026 8-K
8-K Jun 15, 2026 8-K
← Newer Page 1 of 51 · 1265 filings Older →